Trial intelligence / Profile preview

TIVA vs Desflurane Anesthesia in Vitrectomy

NCT02212340Completed

Sponsor
Yonsei University
Start
Jul 2014
Primary completion
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of propofol in vitreoretinal disease (VRD) (2 arms), sponsored by Yonsei University. Primary endpoint: Quality of Recovery-40 Score. Started Jul 2014; status: completed.

02

Drugs

propofol
03

Conditions

vitreoretinal disease (VRD)

Beyond the preview

Go deeper on NCT02212340.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02212340.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call